Nanohumps Biosciences Oy
3407492-1ActivePioneering revolutionary cancer therapies using proprietary nanosized antibodies.
Oversikt
- Ukjent
- Ansatte
- Ukjent
- Omsetning
- 2023
- Grunnlagt
Kontakter
Saara Saaralaulumaa
Beskrivelse
Nanohumps is a pioneering organization focused on developing revolutionary cancer therapies. They specialize in utilizing proprietary nanosized antibodies, known as NanoAbs, as their core technology. The company's primary mission is to overcome the significant limitations associated with current ant...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Ukjent
- Juridisk form
- 16
- MVA-nummer
- FI34074921
Kontakter
1 kontakter i FunnelfeedrSaara Saaralaulumaa
Lignende bedrifter
20 lignende bedrifter i Funnelfeedr
AAX Biotech AB
5–9 ansatteResearch-driven biotech advancing antibody therapies via proprietary technology.
Solid Immuno-Oncology Oy
Developing organ-on-chip technology for advanced cancer treatment decisions.
Roche Oy
Leading global company developing innovative medicines and diagnostics.
Valo Therapeutics Oy
Developing novel peptide-coated oncolytic virus immunotherapies for cancer.
CANTARGIA AB
20–49 ansatteDeveloping antibody-based drugs targeting IL1RAP for serious diseases.
Utforsk mer
Spørsmål om Nanohumps Biosciences Oy
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo